Literature DB >> 2227838

Multicentric Castleman's disease in association with a solitary plasmacytoma: a case report.

S J Gould1, T Diss, P G Isaacson.   

Abstract

Multicentric Castleman's disease with aggressive systemic symptomatology is usually associated with the plasma cell variant. We report a case in which the clinical presentation was typical of multicentric Castleman's disease but which was associated with the hyaline vascular subtype histologically. Plasma cells were absent from all biopsies until, at autopsy, a solitary plasmacytoma was found in the vertebral column. This case supports the view that plasma cells are of primary importance in the clinical and pathological manifestations of multicentric Castleman's disease.

Entities:  

Mesh:

Year:  1990        PMID: 2227838     DOI: 10.1111/j.1365-2559.1990.tb00684.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

1.  Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progression.

Authors:  Haipeng Shao; Liqiang Xi; Mark Raffeld; Stefania Pittaluga; Kieron Dunleavy; Wyndham H Wilson; Nelson Spector; Cristiane Milito; Jose Carlos Morais; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

2.  Unexpected uptake of technetium 99m hexakis-2-methoxy-isobutylisonitrile in giant lymph node hyperplasia of the mediastinum (Castleman's disease).

Authors:  C Aktolun; H Bayhan; B Celasun; M K Kir
Journal:  Eur J Nucl Med       Date:  1991

3.  HIV-associated multicentric Castleman's disease.

Authors:  Fauzia de Fátima Naime; Felipe Fakhouri; Carlos Saraiva Martins; Wilson José Couto
Journal:  Rare Tumors       Date:  2012-09-06

Review 4.  A Review of Genetic Abnormalities in Unicentric and Multicentric Castleman Disease.

Authors:  Alexandra Butzmann; Jyoti Kumar; Kaushik Sridhar; Sumanth Gollapudi; Robert S Ohgami
Journal:  Biology (Basel)       Date:  2021-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.